Literature DB >> 27275426

The association analysis polymorphism of CDKAL1 and diabetic retinopathy in Chinese Han population.

Nai-Jia Liu1, Qian Xiong2, Hui-Hui Wu1, Yan-Liang Li1, Zhen Yang3, Xiao-Ming Tao4, Yan-Ping Du4, Bin Lu1, Ren-Ming Hu1, Xuan-Chun Wang1, Jie Wen1.   

Abstract

AIM: To identify the contribution of CDKAL1 to the development of diabetic retinopathy (DR) in Chinese population.
METHODS: A case-control study was performed to investigate the genetic association between DR and polymorphic variants of CDKAL1 in Chinese Han population with type 2 diabetes mellitus (T2DM). A well-defined population with T2DM, consisting of 475 controls and 105 DR patients, was recruited. All subjects were genotyped for the genetic variant (rs10946398) of CDKAL1. Genotyping was performed by iPLEX technology. The association between rs10946398 and T2DM was assessed by univariate and multivariate logistic regression (MLR) analysis.
RESULTS: There were significant differences in C allele frequencies of rs10946398 (CDKAL1) between control and DR groups (45.06% versus 55.00%, P<0.05). The rs10946398 of CDKAL1 was found to be associated with the increased risk of DR among patients with diabetes.
CONCLUSION: Our findings suggest that rs10946398 of CDKAL1 is independently associated with DR in a Chinese Han population.

Entities:  

Keywords:  CDKAL1; Chinese Han population; association analysis; diabetic retinopathy; polymorphism

Year:  2016        PMID: 27275426      PMCID: PMC4886891          DOI: 10.18240/ijo.2016.05.12

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  32 in total

1.  Type 2 diabetes risk alleles near ADCY5, CDKAL1 and HHEX-IDE are associated with reduced birthweight.

Authors:  E A Andersson; K Pilgaard; C Pisinger; M N Harder; N Grarup; K Faerch; P Poulsen; D R Witte; T Jørgensen; A Vaag; T Hansen; O Pedersen
Journal:  Diabetologia       Date:  2010-05-20       Impact factor: 10.122

2.  Contribution of CDKAL1 rs7756992 and IGF2BP2 rs4402960 polymorphisms in type 2 diabetes, diabetic complications, obesity risk and hypertension in the Tunisian population.

Authors:  Khaled Lasram; Nizar Ben Halim; Houda Benrahma; Sounnia Mediene-Benchekor; Imen Arfa; Sana Hsouna; Rym Kefi; Henda Jamoussi; Slim Ben Ammar; Sonia Bahri; Abdelmajid Abid; Soraya Benhamamouch; Abdelhamid Barakat; Sonia Abdelhak
Journal:  J Diabetes       Date:  2014-04-21       Impact factor: 4.006

3.  Inhibition of cyclin-dependent kinase 5 activity protects pancreatic beta cells from glucotoxicity.

Authors:  Mariano Ubeda; J Michael Rukstalis; Joel F Habener
Journal:  J Biol Chem       Date:  2006-08-03       Impact factor: 5.157

4.  [Association analysis of genetic polymorphisms of TCF7L2, CDKAL1, SLC30A8, HHEX genes and microvascular complications of type 2 diabetes mellitus].

Authors:  Li-li Fu; Ying Lin; Zheng-lin Yang; Yi-bing Yin
Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi       Date:  2012-04

5.  Association analysis of nine candidate gene polymorphisms in Indian patients with type 2 diabetic retinopathy.

Authors:  Suganthalakshmi Balasubbu; Periasamy Sundaresan; Anand Rajendran; Kim Ramasamy; Gowthaman Govindarajan; Namperumalsamy Perumalsamy; J Fielding Hejtmancik
Journal:  BMC Med Genet       Date:  2010-11-10       Impact factor: 2.103

6.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

7.  Association of VEGF gene polymorphisms with diabetic retinopathy in a south Indian cohort.

Authors:  Satagopan Uthra; Rajiv Raman; Bickol N Mukesh; Samuel A Rajkumar; Kumari R Padmaja; Pradeep G Paul; Praveena Lakshmipathy; Perumal Gnanamoorthy; Tarun Sharma; Catherine A McCarty; Govindasamy Kumaramanickavel
Journal:  Ophthalmic Genet       Date:  2008-03       Impact factor: 1.803

8.  Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.

Authors:  Richa Saxena; Benjamin F Voight; Valeriya Lyssenko; Noël P Burtt; Paul I W de Bakker; Hong Chen; Jeffrey J Roix; Sekar Kathiresan; Joel N Hirschhorn; Mark J Daly; Thomas E Hughes; Leif Groop; David Altshuler; Peter Almgren; Jose C Florez; Joanne Meyer; Kristin Ardlie; Kristina Bengtsson Boström; Bo Isomaa; Guillaume Lettre; Ulf Lindblad; Helen N Lyon; Olle Melander; Christopher Newton-Cheh; Peter Nilsson; Marju Orho-Melander; Lennart Råstam; Elizabeth K Speliotes; Marja-Riitta Taskinen; Tiinamaija Tuomi; Candace Guiducci; Anna Berglund; Joyce Carlson; Lauren Gianniny; Rachel Hackett; Liselotte Hall; Johan Holmkvist; Esa Laurila; Marketa Sjögren; Maria Sterner; Aarti Surti; Margareta Svensson; Malin Svensson; Ryan Tewhey; Brendan Blumenstiel; Melissa Parkin; Matthew Defelice; Rachel Barry; Wendy Brodeur; Jody Camarata; Nancy Chia; Mary Fava; John Gibbons; Bob Handsaker; Claire Healy; Kieu Nguyen; Casey Gates; Carrie Sougnez; Diane Gage; Marcia Nizzari; Stacey B Gabriel; Gung-Wei Chirn; Qicheng Ma; Hemang Parikh; Delwood Richardson; Darrell Ricke; Shaun Purcell
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

9.  Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.

Authors:  Eleftheria Zeggini; Michael N Weedon; Cecilia M Lindgren; Timothy M Frayling; Katherine S Elliott; Hana Lango; Nicholas J Timpson; John R B Perry; Nigel W Rayner; Rachel M Freathy; Jeffrey C Barrett; Beverley Shields; Andrew P Morris; Sian Ellard; Christopher J Groves; Lorna W Harries; Jonathan L Marchini; Katharine R Owen; Beatrice Knight; Lon R Cardon; Mark Walker; Graham A Hitman; Andrew D Morris; Alex S F Doney; Mark I McCarthy; Andrew T Hattersley
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

10.  Association analysis in african americans of European-derived type 2 diabetes single nucleotide polymorphisms from whole-genome association studies.

Authors:  Joshua P Lewis; Nicholette D Palmer; Pamela J Hicks; Michele M Sale; Carl D Langefeld; Barry I Freedman; Jasmin Divers; Donald W Bowden
Journal:  Diabetes       Date:  2008-04-28       Impact factor: 9.461

View more
  6 in total

Review 1.  Involvement of Cdkal1 in the etiology of type 2 diabetes mellitus and microvascular diabetic complications: a review.

Authors:  Chandrachur Ghosh; Neeladrisingha Das; Sarama Saha; Tathagata Kundu; Debabrata Sircar; Partha Roy
Journal:  J Diabetes Metab Disord       Date:  2022-01-13

2.  CDKAL1 rs7756992 is associated with diabetic retinopathy in a Chinese population with type 2 diabetes.

Authors:  Danfeng Peng; Jie Wang; Rong Zhang; Feng Jiang; Claudia H T Tam; Guozhi Jiang; Tao Wang; Miao Chen; Jing Yan; Shiyun Wang; Dandan Yan; Zhen He; Ronald C W Ma; Yuqian Bao; Cheng Hu; Weiping Jia
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

3.  The CDKAL1 rs7747752-Bile Acids Interaction Increased Risk of Gestational Diabetes Mellitus: A Nested Case-Control Study.

Authors:  Hui Wang; Jing Li; Junhong Leng; Weiqin Li; Jinnan Liu; Xiaoyan Yan; Zhijie Yu; Gang Hu; Ronald C W Ma; Zhongze Fang; Ying Wang; Xilin Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-10       Impact factor: 5.555

4.  Association of the CDKAL1 polymorphism rs10946398 with type 2 diabetes mellitus in adults: A meta-analysis.

Authors:  Xuekui Liu; Jun Liang; Houfa Geng; Wei Xu; Fei Teng; Manqing Yang
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

5.  Body mass index modulates the association between CDKAL1 rs10946398 variant and type 2 diabetes among Taiwanese women.

Authors:  Oswald Ndi Nfor; Ming-Fang Wu; Chun-Te Lee; Lee Wang; Wen-Hsiu Liu; Disline Manli Tantoh; Shu-Yi Hsu; Kuan-Jung Lee; Chien-Chang Ho; Tonmoy Debnath; Chia-Chi Lung; Yung-Po Liaw
Journal:  Sci Rep       Date:  2018-09-05       Impact factor: 4.379

6.  IGF1 gene polymorphisms associated with diabetic retinopathy risk in Chinese Han population.

Authors:  Jian Zhang; Xiao Chen; Like Zhang; Yi Peng
Journal:  Oncotarget       Date:  2017-09-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.